Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Researchers evaluated the efficacy of semaglutide in patients with the obesity phenotype of heart failure and preserved ejection fraction.

Study reveals how time shifts affect metabolism and sleep

Have you ever felt sluggish and out of sorts after a long-haul flight or a late-night shift? A new study from the University of Surrey

November 20, 2024

Clearmind Medicine Completed Type A Meeting with the FDA | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to

January 11, 2024

Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

Amid ongoing concerns over conflicts of interest, a new study found that 60% of the physicians who served as panel and task force members for

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.